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Abstract 
Using commercially available but powerful big data analytics, this non-clinical obesity and underlying 
causes of death observational study, analyzed the very large US Centers for Disease Control and 
Prevention’s (CDC) State of Obesity records, the CDC WONDER data, and the US census records. 
Compared to the 1999-to-2017 US obesity rate increase of 29.8%, an uncontrolled increase in 
Delaware’s obesity rate (81.7%) was observed.  
During the same time period, CDC WONDER death certificate archives disclosed that there was a 
60.53% surge in crude Delawarean mortality rate when obesity was listed as a single underlying cause 
of death. When any mention of obesity was documented on the death certificate, Delaware’s 1999-2017 
crude mortality rate advanced by 75.69% and its age-adjusted rate rose by 53.18%. Likewise, except 
for one year, Delaware’s African American/Black population experienced higher crude mortality rate 
averages but however, between the years of 1997 and 2017, its Caucasian/White inhabitants had an 
enormous 87.34% death rate increase. With additional available CDC mortality data, Delaware males 
saw substantially larger age-adjusted death rate increases (79.87%) than their female counterparts 
(28.92%). 
Diabetes, circulatory system diseases, and neoplasms (cancer), are three common obesity 
comorbidities. For these three conditions, Delaware’s 1999-2017 mortality rate figures mimic the 
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falling national patterns of mortality rate averages, when each disease is listed as the single underlying 
cause of death, including observations where there are disproportionate numbers of cases that affect 
the African American/Black race.  
Keywords 
Delaware, obesity-related mortality rate, diabetes, diseases of the circulatory system, neoplasms  
 
1. Introduction 
Delaware is the second smallest US state with the fewest counties, New Castle, Kent, and Sussex, and 
it has a relatively minor gender gap, with 52% females and 48% males (Census Bureau, 2015). Last 
year, the US Census Bureau estimated Delaware to have 967,171 people of which 69.5% were 
Caucasian/White (C/W) and at 23.0%, its majority minority race is African American/Black (AA/B) 
(Census Bureau, 2015). On the other hand, the census projected US population was 325,333,856 
(Census Bureau, 2015) with a virtually even gender gap of 49.6% male and 50.4% female, but 
comprised of 76% C/W and 16% AA/B (Dadax, 2019).  
Recent reports indicate a decline in the average US life-expectancy (Mokdad et al., 2018; Olshansky et 
al., 2005; Tuljapurkar, Li, & Boe, 2000) and epidemiological studies hint that life-limiting diseases 
impose enormous social and cost-burden pressures (Mair & May, 2014; Mensah & Brown, 2007; 
Yabroff, Lund, Kepka, & Mariotto, 2011; Yang et al., 2018) on US households and on typical working 
Delawareans (Gill & Mainous, 1998; Gill, Mainous, & Nsereko, 2000; Glickman, Dimagno, & 
Emanuel, 2019). Many of the life-limiting and life-threating illnesses are secondary chronic 
comorbidities that arise from complications due to obesity (Case & Deaton, 2017; National Center for 
Health Statistics, 2017; Weir et al., 2016; Xu, Murphy, Kochanek, Bastian, & Arias, 2018) and together 
with obesity, these conditions have (now) reached a critical public health crisis point (Hales, Carroll, 
Fryar, & Ogden, 2017; Hales, Fryar, Carroll, Freedman, & Ogden, 2018; National Center for Health 
Statistics, 2016). Diabetes, circulatory system diseases, and malignant neoplastic diseases, are three 
directly linked obesity pathologies (Gill et al., 2000; Mair & May, 2014; Mensah & Brown, 2007; 
Mokdad et al., 2018; Yabroff et al., 2011; Yang et al., 2018) that contribute to quality of life issues and 
life-expectancies (Case & Deaton, 2017; National Center for Health Statistics, 2017; Weir et al., 2016; 
Xu et al., 2018).  
The 2017 reported prevalence of Delaware’s adult obesity was 31.8% (Census Bureau, 2015; Ramsey 
et al., 2008). In its three counties, the analogous rates were 29.3%, 38.5%, and 32.6%, for New Castle, 
Kent and Sussex (Christopher et al., 2017; Hales et al., 2017; Ramsey et al., 2008). Delaware’s 
Caucasian/White (C/W) and African American/Black (AA/B) population had 2017 obesity-rates of 
29.7% and 37.4% and in addition, 18.4% of Delaware’s men and 27.2% of its women were obese 
(Christopher et al., 2017; Hales et al., 2017). The corresponding 2017 US obesity-rate was much higher 
(39.6%) (Christopher et al., 2017; Hales et al., 2017; Zhao, Tao, Wang, & Xia, 2019) with 46.8% of the 
AA/B race and 37.9% of the C/W race being obese, and so were 41.1% of the US females and 37.9% 
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of its males (Christopher et al., 2017; Hales et al., 2017). Contrarily, the 1999 Delaware adult 
obesity-rate was far lower (17.5%) (Ramsey et al., 2008) than the corresponding US adult rate (30.5%) 
(Christopher et al., 2017).  
Delaware represents just 0.297% of the US inhabitants (Census Bureau, 2015). Hence this astronomical 
(81.7%) 1999-2017 linear obesity-rate trend unquestionably implies that the obesity epidemic has 
health, social, and financial consequences in the State of Delaware and on the well-being of the nation 
(Bomberg et al., 2017; Dobbs et al., 2014; Kim & Basu, 2016). In fact, the Delaware Health and Social 
Services, Division of Public Health, 2011-2017 Behavioral Risk Factor Survey (BRFS) reports that 
85,400 Delawarean’s (11.3% of the adult population) have diabetes, and 34.9% have hypertension 
(Christopher et al., 2017). Furthermore, even though Delaware is a fraction of the total US populace, 
the National Cancer Institute’s Age-Adjusted Incidence Rates by Cancer Site (2011-2015) listed its rate 
of 493.5 that was 11.8% higher than the USA rate of 441.2 (Ward et al., 2019). 
Big data solutions in the US healthcare arena have clinical value and are transforming managed and 
personalized patient care (Beam & Kohane, 2018; Murdoch & Detsky, 2013; Schneeweiss, 2014). The 
US Centers for Disease Control and Prevention’s (CDC) Wide-ranging Online Data for Epidemiologic 
Research (WONDER) database (Centers for Disease Control and Prevention, 2016b) is an extensive 
public information resource for researchers. Together with the US Census data (Census Bureau, 2015), 
the CDC WONDER’s (Centers for Disease Control and Prevention, 2016b) enormous leading causes of 
death data sets (Park et al., 2018) can be mined by age, gender, geography, and year, for systematic 
incidence analysis of mortality and life-expectancy due to the burden of obesity (Center for Disease 
Control and Prevention, 2016; D’Souza, Li, Gannon, & Wentzien, 2019; D’Souza, 2018; D’Souza, 
Bautista, & Wentzien, 2018; D’Souza et al., 2019; D’Souza et al., 2017; D’Souza et al., 2015; D’Souza, 
Walls, Rojas, Everett, & Wentzien, 2015; D’Souza, Wentzien, Bautista, & Gross, 2017; Grover et al., 
2015; Johnson et al., 2014; National Center for Health Statistics, 2016, 2017; Neff & D’Souza, 2019; 
Park et al., 2018; Schneeweiss, 2014; Voss, Pavela, & Stanford, 2018). The CDC WONDER database 
includes certifying cause of death categories (Centers for Disease Control and Prevention, 2016b; Park 
et al., 2018) using the Tenth Revision of the International Classification of Diseases (ICD-10) coding 
(Gonzalez & Chiodo, 2015; WHO, 2010). ICD-10 coding reporting errors (D’Souza, 2018; McGivern, 
Shulman, Carney, Shapiro, & Bundock, 2017; Pritt, Hardin, Richmond, & Shapiro, 2005) are well 
known, but together with research on the increased US waist size (Bentham et al., 2017; Hales et al., 
2018) has generated valuable awareness on the negative impacts (D’Souza, Li, Gannon, & Wentzien, 
2019; Jia & Lubetkin, 2005; Johnson et al., 2014; Leonard et al., 2015; Masters et al., 2013; Singh, 
Kochanek, & MacDorman, 1996; Tomlinson, Erskine, Morse, Winwood, & Onambélé-Pearson, 2016; 
Tomlinson, Erskine, Winwood, Morse, & Onambélé, 2014) of the nation’s waistline on human health 
(Centers for Disease Control and Prevention, 2016b; D’Souza, Li, Gannon, & Wentzien, 2019; 
D’Souza, 2018; D’Souza et al., 2018; D’Souza et al., 2015; D’Souza et al., 2015; D’Souza et al., 2019; 
D’Souza et al., 2017; Flegal, 2006; Flegal, Graubard, Williamson, & Gail, 2007; Guh et al., 2009; 
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Kopelman, 2007; Malnick & Knobler, 2006; Martí, 2016; O’Malley et al., 2005; O’Neill & O’Driscoll, 
2015; Pi-Sunyer, 2009; Rudisill, Charlton, Booth, & Gulliford, 2016; Rzechonek et al., 2018; Siegel, 
Miller, & Jemal, 2019). 
Incorporating data mining techniques on US census, health, mortality surveys (Census Bureau, 2015; 
Centers for Disease Control and Prevention, 2016a, 2016b; Centers for Disease Control and Prevention 
& National Center for Health Statistics, 2017; National Center for Health Statistics, 2016, 2017; Park et 
al., 2018) and spatial analysis visualization methods (Kanazawa & Kanazawa, 2018; Morra, 2018), 
prior work (clearly) demonstrated reasonable associations for the premature obesity-related impacts on 
mortality and morbidity in the general US population (D’Souza, Li, Gannon, & Wentzien, 2019; 
D’Souza et al., 2015; D’Souza et al., 2019; Guh et al., 2009; Neff & D’Souza, 2019; Siegel et al., 2019; 
Voss et al., 2018) and in the occupants of Delaware (D’Souza et al., 2015; D’Souza et al., 2015; 
D’Souza et al., 2017; Neff & D’Souza, 2019). 
The delineated 1999-2017 national obesity-related mortality data not only displayed appreciable 
ascending rates, but exposed increased racial disparities that has principally affected the nations AA/B 
race as their age-adjusted mortality rates were significantly (p < 0.05) higher than the US national 
average for documented deaths due to obesity, diabetes, diseases of the circulatory system, and 
neoplasms (D’Souza, Li, Gannon, & Wentzien, 2019; D’Souza et al., 2019). Additionally, when 
analyzed in detail, for diabetes, the younger decennial age-groups 15-24, 25-34, 35-44, and 45-54 had 
positive upward trending percentages of 42.2%, 25.65%, 20.24%, and 16.8% respectively. Under the 
other listed disease conditions and as would be expected for deaths due to malignant neoplasms and the 
diseases of the circulatory system, the upper-middle age and older Americans had crude mortality rates 
that were higher than the national average (D’Souza, Li, Gannon, & Wentzien, 2019).  
Our recent observational findings (D’Souza, Li, Gannon, & Wentzien, 2019; D’Souza et al., 2018; 
D’Souza et al., 2017; D’Souza et al., 2015; D’Souza et al., 2015; Grover et al., 2015; Neff & D’Souza, 
2019; Voss et al., 2018) on evaluating national CDC WONDER data (Centers for Disease Control and 
Prevention, 2016b; Centers for Disease Control and Prevention & National Center for Health Statistics, 
2017; Park et al., 2018), plainly prove that there is an earlier risk of dying due to obesity and related 
comorbidity conditions. Hence, it is imperative that this project carefully investigate the risk of 
premature death that is associated with obesity in Delaware.  
 
2. Methods 
The data for this study was obtained from CDC WONDER (Centers for Disease Control and 
Prevention, 2016b; Centers for Disease Control and Prevention & National Center for Health Statistics, 
2017; Park et al., 2018). The CDC collects and compiles the data from the death certificates reported 
from all 50 states and the District of Columbia and it calculates age-adjusted mortality rates and 
confidence interval limits to permit comparisons between demographic groups over time. The data was 
downloaded into a M.S. Excel dataset utilizing the query menu-driven access tools and line graphs 
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generated using the Statistical Analysis System (SAS) software. The following ICD-10 codes were 
used: Obesity E66, Diabetes mellitus E10-E14, Diseases of the circulatory system I00-I99, and 
Neoplasms C00-D48. 
The age-adjusted mortality rates were determined using year 2000 population distributions as the 
reference population (Anderson & Arias, 2003; Anderson & Rosenberg, 1998). The effect of a change 
in mortality rates due to a change in the age distribution of a population is minimized using the 
age-adjusted rates thereby permitting a more affective analysis of mortality rates over time (Anderson 
& Arias, 2003; Anderson & Rosenberg, 1998). Age-adjusted rates cannot be calculated when the data 
are grouped by age group, decennial mortality are based on crude rates that are utilized when the death 
count is less than 20 (National Center for Health Statistics, 2017). Age-adjusted mortality rates for 
diabetes, diseases of the circulatory system, and neoplasms, between 1999 and 2017 were obtained and 
analyzed. 
Confidence interval limits for the age-adjusted mortality rates were calculated and used in the line 
graphs to observe any statistically significant differences between demographic groups. Although all 
available records from the death certificates were used to construct the age-adjusted mortality rates, 
confidence interval limits were calculated because of the error that might occur from inaccurate or 
inconsistent reporting on the death certificates. Line graphs displaying the 95% confidence intervals for 
the age-adjusted mortality rates of diabetes, diseases of the circulatory system, and neoplasms, between 
1997 and 2017 were constructed by gender and race groups. Changes in the mortality rates were then 
calculated and added to the line graphs. The datasets were downloaded into MS-Excel, and the SAS 
program was used for graph creation. For the race categories, to highlight the confidence intervals (CI), 
confidence bands are used to show the confidence limits. 
 
3. Results and Discussion 
From 1999 to 2017, Figure 1 shows that there was a 60.53% increase in Delaware’s crude mortality 
rate (number of deaths per year, per 100,000 individuals) where the physician listed obesity as the 
single (specific) underlying cause of death. Figure 2 presents both the 1999-2017 crude mortality 
increase (75.69%) and the age-adjusted (mathematically adjusted to allow for more comparable 
comparisons between differing age groups) death rate increase (53.18%) when any certified mention of 
obesity was on the death record. The crude rate is higher due to the absence of possible age-specific 
distortions. 
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Figure 1. 1999-2017 Crude Mortality Rates in Delaware Where Obesity was Listed as the Single 
Underlying Cause of Death 
 
 
Figure 2. 1999-2017 Crude and Age-adjusted Mortality Rates in Delaware Where There was any 
Mention of Obesity on the Death Certificate 
 
In spite of the 2017 prevalence of adult obesity data showing that only 18.4% of Delaware men were 
obese compared to 27.2% of its women (Christopher et al., 2017; Hales et al., 2017), the Figure 3 male 
and female age-adjusted mortality rates exhibits a fluctuating pattern with a serious hike in 1999-2017 
death rates for males (79.87%), where obesity was present in the deceased but not necessarily listed as 
the underlying cause of death. This jump in age-adjusted moratlity for Delawarean males can be 
rationalized due to the harmful implications of visceral fat (Centers for Disease Control and Prevention, 
2016b; D’Souza, Li, Gannon, & Wentzien, 2019; D’Souza, 2018; D’Souza et al., 2018, 2019; D’Souza 
et al., 2015; D’Souza et al., 2015; D’Souza et al., 2017; Flegal, 2006; Flegal et al., 2007; Guh et al., 
2009; Kopelman, 2007; Malnick & Knobler, 2006; Martí, 2016; O’Malley et al., 2005; O’Neill & 
O’Driscoll, 2015; Pi-Sunyer, 2009; Rudisill et al., 2016; Rzechonek et al., 2018; Siegel et al., 2019).  
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Figure 3. 1999-2017 Male and Female Age-adjusted Mortality Rates in Delaware Where There 
was any Mention of Obesity on the Death Certificate 
 
In Delaware and in the US, the AA/B race has more advanced rates of obesity than their C/W 
counterparts (Christopher et al., 2017; Hales et al., 2017). Their 2017 Delaware adult obesity rates were 
37.4% and 29.7% respectively (Christopher et al., 2017; Hales et al., 2017). This growing unchecked 
racial obesity imbalance appears in all of Delaware’s 1999-2017 death certificate records where except 
for one year, the crude AA/B mortality rates with any mention of obesity on the death certificate was 
always considerably higher than the comparable C/W mortality rates. Crude rates were used in Figure 4 
due to the year 1999 having unreliable data to account for age-adjustment. Nonetheless for the C/W 
race, Figure 4 marks the risk of dying with a sobering statistic (87.34%) when obesity is mentioned on 
the death record (between 1997 and 2017).  
 
 
Figure 4. 1999-2017 Black and White Crude Mortality Rates in Delaware Where There was any 
Mention of Obesity on the Death Certificate 
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Prior national age-adjusted investigations determined that for males and the AA/B population, the 
mortality rates where obesity was listed as a contributory death factor, was unmistakely higher than the 
analogous general population national averages (Christopher et al., 2017; Hales et al., 2017). Yet, it 
should be pointed out that the US obesity prevalence (Bentham et al., 2017; Hales et al., 2018) is 
touching all segments of its population (D’Souza, Li, Gannon, & Wentzien, 2019; Jia & Lubetkin, 2005; 
Johnson et al., 2014; Leonard et al., 2015; Masters et al., 2013; Singh et al., 1996; Tomlinson et al., 
2016, 2014) and a number of negative health affects are directly attributable to obesity (Centers for 
Disease Control and Prevention, 2016b; D’Souza, Li, Gannon, & Wentzien, 2019; D’Souza, 2018; 
D’Souza et al., 2018, 2019; D’Souza et al., 2015; D’Souza et al., 2015; D’Souza et al., 2017; Flegal, 
2006; Flegal et al., 2007; Guh et al., 2009; Kopelman, 2007; Malnick & Knobler, 2006; Martí, 2016; 
O’Malley et al., 2005; O’Neill & O’Driscoll, 2015; Pi-Sunyer, 2009; Rudisill et al., 2016; Rzechonek 
et al., 2018; Siegel et al., 2019). Moreover, the 35-44 age-group (nationwide) realized the highest 
1999-2016 crude death rate increase (174.93%) (D’Souza et al., 2019).  
The age-specific death rates where there was any mention obesity for the decennial age-groups studied, 
are shown in Figure 5. In line with the national trend, Figure 5 pinpoints that Delaware’s highest 
2001-2017 mortality rate (91.94%) is also occurring in the younger 35-44 adult age-group range. A 
negative (-17.60%) mortality rate was observed for the 45-54 age-group while the upper middle-age 
(55-64) and older (64-74) age-groups had much higher mortality rates at 77.41% and 79.51% 
respectively.  
For the secondary obesity conditions and cormorbidities, the declining Figure 6 pattern of Delaware’s 
1997-2017 age-adjusted mortality rate changes conform to the national patterns where ciculatory 
system diseases show up to be the number one cause of death. Additionally, Delaware’s distinguishing 
single underlying cause of death averages for diabetes and the diseases of the circulatory system, 
almost coincide with the national trending line but are slighlty higher than the national averages for 
deaths associated with neoplasms (Figure 6). For the dominant Delaware races, C/W and AA/B, 
Figures 7-9 exhibit disproportionate 1999-2017 age-adjusted mortality rates due to diabetes, diseases of 
the circulatory system, and neoplasms. For the AA/B and C/W Delawareans, ninety-five percent 
confidence intervals (95% CI) are provided for the 1999 and 2017 age-adjusted mortality rates 
associated with the three obesity-related diseases (Table 1). Likewise to assist in interpreting Figures 
7-9, confidence limits are added to offer visual measures of the probability and magnitude of the 
observed AA/B and C/W disparities.  
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Figure 5. 2001-2017 Decennial Age-specific Mortality Rates in Delaware Where There was any 
Mention of Obesity on the Death Certificate 
 
 
Figure 6. National Average Comparison of Delaware’s 1999-2017 Age-adjusted Mortality Rates 
Due to Diabetes, Diseases of the Circulatory System, and Neoplasms 
 
 
Figure 7. Delaware’s 1999-2017 Diabetes Age-adjusted Mortality Rates 
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Figure 8. Delaware’s 1999-2017 Age-adjusted Mortality Rates Due to Diseases of the Circulatory 
System 
 
 
Figure 9. Delaware’s 1999-2017 Age-adjusted Mortality Rates Due to Neoplasms 
 
For the AA/B race, the 1999-2017 age-adjusted mortality rates due to diabetes trend lower but are at a 
level that is very inflated to what is observed for the C/W race and where there is a complete lack of 
overlap in the 95% CI’s (Figure 7) from one year to the next. For the diseases of the circulatory system 
(Figure 8), the AA/B age-adjusted death rate is higher than C/W’s detected rate and there is a very 
slight overlap in the 95% CI’s, whereas in Figure 9 (age-adjusted neoplasm mortality rates), the 
two-race 95% CI’s moderately overlay at several points, even though the AA/B rate is at a slightly 
expanded level when compared to the C/W rate. 
The Figures 10-12 and Table 2 testify to the influences that diabetes, circulatory system diseases, and 
neoplasms have on Delawarean’s 1999-2017 crude death rates for specific age groups. In addition 
(Figures 13-15) for the same time frame, and for each of the three Delaware counties (New Castle, 
Kent, and Sussex), population-based age- adjusted mortality rate frequency statistics are also tracked. 
Complementary to what transpired in the national 1999-2017 crude mortality rate analysis (D’Souza, Li, 
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Gannon, & Wentzien, 2019; D’Souza et al., 2017) for the three diseases (single underlying cause of 
death in each case), the Delaware mortality rates exhibit a declining pattern for the ten-year population 
age-groups except in the case of diabetes, where for the 45-54 and 55-64 age-group intervals and 
between the two 1999 and 2017 time points, the mortality rates are found to be largely growing by 
76.75% and 25.92% respectively. 
When the age data and number of deaths per 100,000 (Figures 13-15) are analyzed by county (from 
1997 to 2017), the age-adjusted single underlying cause of death rates due to the diseases of the 
circulatory system, and neoplasms, are largely dropping in New Castle, Kent and Sussex counties. For 
the condition of diabetes, the death rate has gently increased (2.88%) in New Castle County, but in 
great measure, decreased in Kent (-30.32%) and Sussex counties (-43.22%). The 1997-to-2017 rise in 
diabetes related age-adjusted mortality rates in New Castle County is a probable artifact of relating the 
two time points, as New Castle County was shown to have the lowest 2017 obesity and diabetes 
prevalence [21], [22].  
 
Table 1. Delaware’s Age Adjusted Mortality Rates by Race 
Year Race Disease Rate 95% CI 
1999 
White 
Black or African American 
Diabetes 
26.66 
58.24 
[22.18, 31.14] 
[41.61, 86.19] 
 
White 
Black or African American 
Neoplasms 
279.96 
381.44 
[265.63, 294.30] 
[336.45, 426.42] 
 
White 
Black or African American 
Diseases of the 
Circulatory System 
419.57 
488.82 
[401.72, 437.41] 
[436.90, 540.73] 
2017 
White 
Black or African American 
Diabetes 
20.82 
42.22 
[17.57, 24.07] 
[32.79, 53.53] 
 
White 
Black or African American 
Neoplasms 
207.43 
244.52 
[197.30, 217.55] 
[219.87, 269.17] 
 
White 
Black or African American 
Diseases of the 
Circulatory System 
272.86 
318.99 
[261.21, 284.51] 
[289.78, 348.21] 
Note. Data from CDC WONDER Database; CI = Confidence Interval 
 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 4, No. 4, 2019 
338 
Published by SCHOLINK INC. 
 
Figure 10. 1999-2017 Delaware’s Crude Mortality Rates Due to Diabetes for the Age-groups, 
45-54, 55-64, 65-74, 75-84, and 85+ 
 
 
Figure 11. 1999-2017 Delaware’s Crude Mortality Rates Due to Diabetes for the Age-groups, 
35-44, 45-54, 55-64, 65-74, 75-84, and 85+ 
 
 
Figure 12. 1999-2017 Delaware’s Crude Mortality Rates Due to Neoplasms for the Age-groups, 
35-44, 45-54, 55-64, 75-84 and 85+ 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 4, No. 4, 2019 
339 
Published by SCHOLINK INC. 
 
Figure 13. 1999-2017 Delaware’s Crude Mortality Rates Due to Neoplasms for the Age-groups, 
15-24, 25-34, 35-44, and 45-54 
 
 
Figure 14. 1999-2017 Delaware’s Crude Mortality Rates Due to Neoplasms for the Age-groups, 
15-24, 25-34, 35-44, and 45-54 
 
 
Figure 15. 1999-2017 Delaware’s Crude Mortality Rates Due to Neoplasms for the Age-groups, 
15-24, 25-34, 35-44, and 45-54 
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Table 2. Crude Mortality Rates by Decennial Age-groups 
Year Age Group Disease Rate 95% CI 
1999 45-54 
55-64 
65-74 
75-84 
85+ 
Diabetes 9.92 
35.77 
81.86 
137.63 
410.20 
[4.76, 18.24] 
[23.15, 52.81] 
[59.93, 109.19] 
[101.12, 183.02] 
[295.63, 554.47] 
 
35-44 
45-54 
55-64 
65-74 
75-84 
85+ 
Neoplasms 52.83 
130.92 
403.51 
934.25 
1607.61 
2090.05 
[40.94, 67.09] 
[108.58, 153.25] 
[356.42, 450.61] 
[854.33, 1014.16] 
[1473.14, 1742.09] 
[1810.02, 2370.08] 
 
35-44 
45-54 
55-64 
65-74 
75-84 
85+ 
Diseases of the 
Circulatory System 
45.73 
115.05 
283.32 
943.14 
2430.45 
7432.3 
[34.73, 59.12] 
[94.11,135.98] 
[243.85, 322.78] 
[862.85, 1023.44] 
[2265.10, 2595.80] 
[6904.30, 7960.44] 
2017 45-54 
55-64 
65-74 
75-84 
85+ 
Diabetes 17.53 
45.04 
61.22 
103.86 
199.84 
[10.98, 26.53] 
[34.37, 57.97] 
[47.14, 78.17] 
[77.57, 136.21] 
[142.10, 273.18] 
 
35-44 
45-54 
55-64 
65-74 
75-84 
85+ 
Neoplasms 23.57 
102.76 
315.25 
629.38 
1122.54 
1690.92 
[15.40, 34.53] 
[85.03, 120.50] 
[285.10, 345.40] 
[581.29, 677.47] 
[1029.73, 1215.35] 
[1508.48, 1873.36] 
 
35-44 
45-54 
55-64 
65-74 
75-84 
85+ 
Diseases of the 
Circulatory System 
38.07 
113.12 
213.92 
502.17 
1282.33 
5467.31 
[27.44, 51.46] 
[94.51, 131.72] 
[189.09, 238.76] 
[459.21, 545.12] 
[1183.14, 1381.53] 
[5139.25, 5795.36] 
Note. Data from CDC WONDER Database; CI = Confidence Interval 
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4. Conclusions 
The burden of obesity as a primary or secondary indicator as documented in the CDC’s cause of death 
data, paints an alarming picture for all Delawareans. Furthermore, the mortality records indicate that 
the African American/Black population is disproportionately affected when obesity, diabetes, diseases 
of the circulatory system, or neoplasms, are listed as the single underlying cause of death. 
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